je.st
news
Tag: alexion
Alexion Pharma to pay $8.4 billion for Synageva BioPharma
2015-05-06 18:14:05| Biotech - Topix.net
Alexion Pharmaceuticals will pay a huge premium to buy Synageva BioPharma in an $8.4-billion deal for a rare disease treatment maker that lost nearly $60 million in the first quarter and has no products on the market.
Tags: pay
billion
pharma
biopharma
The Wall Street Journal: Alexion to buy Synageva in $8.4 billion biotech deal
2015-05-06 13:59:13| Biotech - Topix.net
Alexion Pharmaceuticals Inc. has agreed to buy Synageva BioPharma Corp. in a cash-and-stock deal valued at $8.4 billion, a move that will strengthen Alexion's pipeline of rare-disease treatments. shareholder will receive $115 in cash and 0.6581 Alexion share, for a total consideration of about $225.92 a share based on Alexion's After the deal, Alexion will have eight treatments in clinical trials, including Synageva's experimental enzyme-replacement therapy for patients with mucopolysaccharidosis IIIB, a rare metabolic disease.
20 Job Openings in Cheshire: Alexion Pharmaceuticals, Cheshire Academy, United Technologies and More
2014-11-30 02:31:21| Biotech - Topix.net
Sr Manager / Associate Director, Global aHUS Marketing Reports to: Director, Global aHUS Medical Marketing Location: Cheshire, CT Alexion Pharmaceuticals, Inc. is a... One of our clients a publicly listed with 2 Billion Dollars in revenue BioPharmaceutical company is looking for an Associate Director of Finance to join their team, this role will... IT Validation Manager will be responsible for registration and validation of IT systems.
Tags: more
united
job
technologies
Alexion Pharma co-founder Squinto to retire
2014-11-10 23:55:27| Biotech - Topix.net
Alexion Pharmaceuticals has named Senior Vice President Julie O'Neill to replace company co-founder Stephen Squinto when the executive vice president and chief global operations officer retires Jan. 1 O'Neill currently oversees global manufacturing operations and serves as Alexion's general manager for Ireland. She joined the company last February.
Tags: retire
pharma
cofounder
alexion
Alexion Announces the Appointments of David R. Brennan, M. Michele...
2014-07-16 21:50:51| Biotech - Topix.net
Alexion Pharmaceuticals, Inc. today announced the appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to the Company's Board of Directors, effective immediately.
Tags: david
announces
appointments
michele